本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR
DC Funds, LP (CIK 1869028) reported $1.3M across 3 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: TCRX ($617,463, 49.27%), BRNS ($423,855, 33.82%), HOWL ($212,018, 16.92%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | TCRX | TSCAN THERAPEUTICS INC | $617,463 | 49.27% | 630,000 | Hold |
| 2 | BRNS | BARINTHUS BIOTHERAPEUTICS PL | $423,855 | 33.82% | 642,204 | Hold |
| 3 | HOWL | WEREWOLF THERAPEUTICS INC | $212,018 | 16.92% | 589,102 | Hold |
来源：SEC 13F 申报文件 · 截至 2026-06-30